Lv2
166 积分 2024-09-18 加入
Structural Optimization and Radiolabeling of EphA2-Targeted Bicyclic Peptides for Tumor Theranostics
13天前
已完结
Preclinical Evaluation of 89Zr-Labeled Anti-Nectin-4 Antibody for Enhanced PET Imaging in Bladder Urothelial Carcinoma
1个月前
已完结
A Novel Radiotracer for NTSR1-Targeted PET Imaging of Tumor: Preclinical and First-in-Human Studies
1个月前
已完结
68 Ga-Labeled Dimeric Cyclic Peptide for Nectin-4–Targeted PET Imaging: From Preclinical Evaluation to First-in-Human Imaging in Breast Cancer
1个月前
已关闭
[68Ga]Ga-NECT-224 PET/CT Shows Increasing Nectin-4 Expression in Progressive Urothelial Carcinoma Under ADC-Therapy With Enfortumab-Vedotin
2个月前
已完结
Multicyclic Peptides Targeting PD-L1 for Radiotheranostics: From Discovery to Clinical Proof-of-Concept
2个月前
已完结
Development and Preclinical Evaluation of CDH17-Specific ImmunoPET Imaging in Colorectal Cancers
2个月前
已完结
[ 68 Ga]Ga-NECT-224 PET/CT Shows Increasing Nectin-4 Expression in Progressive Urothelial Carcinoma Under ADC-Therapy With Enfortumab-Vedotin
2个月前
已关闭
Design and preclinical evaluation of lipophilicity-enhanced bicyclic peptide probes targeting Nectin4 Labeled with 68Ga/18F
2个月前
已完结
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
2个月前
已完结
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [ 68 Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer
6个月前
已采纳
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [ 68 Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer
6个月前
已采纳
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer
6个月前
已采纳
Dynamics, Pharmacokinetics, and Dosimetry of First-in-Human [68Ga]Ga-OncoACP3-DOTA PET in Patients with Prostate Cancer
6个月前
已采纳